X

pharmaceuticals

Covid vaccine won’t dent Ampio Pharma’s market: CEO Michael Macaluso

Since its foundation in 2008, Ampio Pharmaceuticals (NYSE: AMPE) has been focused on delivering a drug that treats inflammation caused…

Johnson & Johnson’s (JNJ) COVID-19 vaccine would have an edge over others without this glitch

Johnson & Johnson (NYSE: JNJ) saw its shares climb 2% on Thursday after the company reported positive results from the…

Rite Aid (RAD) looks to regain lost ground with new rebound strategy

Rite Aid Corporation (NYSE: RAD) is on a mission to put the house in order and achieve sustainable profitability, after…

Trxade Group Inc. (NASDAQ: MEDS) Q4 2020 Research Summary

Ticker MEDSExchange NASDAQFounded 2013Headquarters FloridaIndustry TechnologyMarket Cap $45 million Trxade Group Inc (NASDAQ: MEDS) has been serving pharmacies and drug…

COVID vaccine: Single-dose regimen can give Johnson & Johnson (JNJ) an edge

Johnson & Johnson (NYSE: JNJ) has adopted a slow and steady approach in its COVID vaccine research, which is one…

Rite Aid Corporation (RAD) Q3 2021 Earnings Call Transcript

Rite Aid Corporation (NYSE: RAD) Q3 2021 earnings call dated Dec. 17, 2020. Corporate Participants: Trent Kruse -- Senior Vice President, Investor…

Infographic: Highlights of Rite Aid’s (RAD) Q3 2021 earnings report

Rite Aid Corporation (NYSE: RAD) reported a decline in third-quarter earnings, despite an increase in revenues, as margins were hurt…

Alexion’s long-term prospects remain intact amid continued focus on rare diseases

Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) has stood out in the crowded pharmaceuticals marketplace by developing effective treatments for certain rare health…

Is it the right time to invest in Agilent Technologies (A)?

Agilent Technologies, Inc. (NYSE: A) ended fiscal 2020 on a positive note, bettering its performance consistently after experiencing a slowdown…

COVID-19 vaccine: These pharma companies have also made headway

The month of November has been huge for pharmaceutical companies with many submitting positive results from their clinical trials for…

Merck (MRK) acquires OncoImmune to add another drug to its COVID-19 pipeline

Merck (NYSE: MRK) announced the acquisition of privately-held biopharma company OncoImmune for an upfront payment of $425 million in cash…

Current focus is on scaling up capabilities: 10x Genomics CEO Serge Saxonov

10x Genomics, Inc. (NASDAQ: TXG), a pioneer in single-cell genomics, has been eliciting significant investor interest ever since it went…

Pfizer concludes COVID-19 vaccine trial with efficacy of 95%; will apply for EUA within days

Pfizer Inc. (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) announced the completion of the Phase 3 clinical trial…

Can COVID vaccine be a panacea for Novavax’s (NVAX) growth needs?

The market has been closely following the activities of leading biopharma companies for some time, looking for updates on their…

Biogen (BIIB) might need to revisit pipeline after Alzheimer’s drug setback

The controversy surrounding biotechnology firm Biogen's (NASDAQ: BIIB) Alzheimer's drug Aducanumab took a positive turn last week after the FDA…

Affimed N.V. (AFMD) Q3 2020 Earnings Call Transcript

Affimed N.V.  (NASDAQ: AFMD) Q3 2020 earnings call dated Nov. 10, 2020 Corporate Participants: Alexander Fudukidis -- Head of Investor Relations Adi…

Pfizer (PFE) gains on data showing 90% efficacy for COVID-19 vaccine candidate

Shares of Pfizer Inc. (NYSE: PFE) rallied on Monday after the company reported positive results from its Phase 3 trial…

Infographic: Highlights of Aurora Cannabis’ (ACB) Q1 2021 earnings report

Aurora Cannabis, Inc. (NYSE: ACB) reported a loss for the first quarter of 2021, continuing the recent trend. However, the…

Infographic: Highlights of Cronos Group (CRON) Q3 2020 earnings report

Marijuana company Cronos Group Inc. (NASDAQ: CRON) on Thursday reported financial results for the third quarter of 2020. Revenues increased…

Bristol-Myers Squibb beats in Q3, raises guidance

Bristol-Myers Squibb Company (NYSE: BMY) reported third-quarter 2020 financial results before the market opened on Thursday. The pharmaceutical company reported…

GW Pharmaceuticals stock jumps 20% on Epidiolex strength

GW Pharmaceuticals (NASDAQ: GWPH) reported third-quarter 2020 financial results before the regular trading hours on Tuesday. The company, which specializes…